The case for testing Pfizer’s Paxlovid for treating long COVID
Reports of two patients who found relief from long COVID after taking Pfizer’s antiviral Paxlovid, including a researcher who tested it on herself, …
Read more
Omicron-specific Sinopharm COVID vaccine cleared for trial
Two COVID-19 vaccine candidates developed by units of China National Biotec Group (CNBG) to target the Omicron variant were approved for clinical tr…
Read more
COVID-19 may increase risk for rare eye clots
Patients with COVID-19 may have an increased risk of rare vision-threatening blood clots in the eye for months afterward, new findings suggest. Bec…
Read more
Fourth vaccine dose protects vs Omicron for at least a month
A fourth dose of the COVID-19 vaccine from Pfizer and BioNTech provided significant added protection against severe disease, hospitalization and dea…
Read more
UK approves Moderna’s COVID shot for 6-11 year-olds
UK’s medicines regulator on Thursday approved the use of Moderna’s (MRNA.O) COVID-19 vaccine in children between six and 11 years, as the country bo…
Read more
Pfizer says booster dose increases protection against Omicron
A third dose of Pfizer Inc and BioNTech’s COVID vaccine produced significant protection against the Omicron variant in healthy children aged between…
Read more
Americans urged to dispose of some Kinder products
Ferrero on Tuesday asked US consumers to dispose of some Kinder chocolate products not authorized for distribution in the country, warning they coul…
Read more
Social Plugin